Best Medical Device Development Companies

StarFish Medical vs Sagentia Innovation: full comparison for 2026

Quick verdict

StarFish Medical (4.6/5) edges ahead of Sagentia Innovation (4.1/5) overall. StarFish Medical is the better choice for startups needing design plus pilot manufacturing. Sagentia Innovation is the stronger option for surgical robotics and combination products. The right choice depends on your project size, budget, and required tech stack.

StarFish Medical vs Sagentia Innovation: head-to-head summary

Criterion StarFish Medical Sagentia Innovation
Founded 1999 1986
HQ Victoria, BC, Canada Harston, Cambridge, UK
Team size 201–250 650+ (Science Group)
Rating 4.6 / 5 4.1 / 5
Primary differentiator Medtech-only practice that can build clinical and early commercial units in its own certified clean room Medical development backed by a listed science group that also runs a regulatory consultancy
Pricing model Phased fixed project, time and materials Time and materials, fixed project
Min. engagement Not disclosed Not disclosed
Primary tech stack ISO 13485 QMS, IEC 62304, ISO 14971 Embedded C/C++, Robotics, Mechanical simulation
Industries served Diagnostics & lab devices, Surgical & therapeutic devices, Wearables & remote monitoring, Drug delivery Surgical & robotics, Drug delivery, Diagnostics & lab devices

StarFish Medical vs Sagentia Innovation: overview

StarFish Medical

StarFish Medical was founded in Victoria, British Columbia, by Scott Phillips (the company gives 1999; some directories list 1998). It works only on medical devices, covering design, development and low-volume manufacturing in ISO 13485 certified facilities, and reports around 230 staff across Victoria, Toronto and Irvine (per company website; independently unverifiable). In November 2024 it acquired Omnica Corporation, a California medical device design firm, which added a larger US West Coast presence. Victoria remains the headquarters and its largest site.

Sagentia Innovation

Sagentia Innovation is owned by Science Group plc, which is listed on the London Stock Exchange's AIM market. Its roots go back to 1986; the current business was formed in 2021 from Sagentia, OTM Consulting and Oakland Innovation. It is based at Harston Mill near Cambridge, with R&D facilities in Cambridge and Epsom, and its medical work covers devices, combination products and surgical robotics. Science Group employs more than 650 people across all its businesses.

Services and capabilities: StarFish Medical vs Sagentia Innovation

Capability StarFish Medical Sagentia Innovation
Electronics & PCB design ✓ ✓
Firmware & embedded software ✓ ✓
SaMD & companion apps ✗ ✗
Connected devices & IoT ✗ ✗
Industrial design & human factors ✓ ✗
Mechanical engineering ✓ ✓
Device cybersecurity ✗ ✗
Regulatory & QMS support ✓ ✓
Manufacturing & scale-up ✓ ✗

Tech stack comparison: StarFish Medical vs Sagentia Innovation

Framework / platform StarFish Medical Sagentia Innovation
Embedded C/C++ ✓ ✓
Embedded Linux N/A N/A
RTOS N/A N/A
BLE N/A N/A
Cloud (AWS/Azure) N/A N/A
IEC 62304 ✓ N/A
ISO 14971 ✓ N/A
ISO 13485 QMS ✓ ✓
Qt N/A N/A

Pricing comparison: StarFish Medical vs Sagentia Innovation

Criterion StarFish Medical Sagentia Innovation
Minimum engagement Not disclosed Not disclosed
Engagement models Fixed project, Manufacturing contract, Time & materials Consulting, Fixed project, Time & materials
Rate transparency Not public Not public
Price tier Mid-market Mid-market

Target audience comparison: StarFish Medical vs Sagentia Innovation

Dimension StarFish Medical Sagentia Innovation
Best company size Startup to mid-market Startup to mid-market
Best industries Diagnostics & lab devices, Surgical & therapeutic devices, Wearables & remote monitoring Surgical & robotics, Drug delivery, Diagnostics & lab devices
Best use cases Taking a venture-backed device from proof of concept to clinical-trial units, Designing an optical diagnostic instrument with its consumable Surgical robot subsystem development, Drug-device combination product engineering
Typical project type Fixed project Consulting

StarFish Medical vs Sagentia Innovation: pros and cons

StarFish Medical
+ Every project is a medical device, so design reviews, risk files and documentation follow medtech practice by default
+ Prototype and pilot production happen in its own ISO 13485 facility, avoiding an early transfer to a contract manufacturer
+ The Omnica acquisition adds Southern California capacity for US clients
+ Multidisciplinary teams cover industrial design, mechanics, electronics, software and human factors
- Volume manufacturing beyond pilot quantities still needs a larger contract manufacturer
- North American cost base makes it more expensive than Eastern European or Asian engineering teams
- The Omnica integration is recent, so cross-site processes are still settling
Sagentia Innovation
+ Active surgical robotics software and hardware hiring shows current work in that area
+ Sister business TSG Consulting has a medical device regulatory team
+ Large owned R&D facilities in Cambridge and Epsom
+ About 30 years of medical device projects
- Part of a listed group, so commercial priorities answer to public shareholders
- Recent 2021 merger means the brand and teams are relatively new
- Science Group headcount covers many businesses, so the medtech team size is unclear

Who should choose StarFish Medical?

A typical fit: taking a venture-backed device from proof of concept to clinical-trial units.

Medtech-only practice that can build clinical and early commercial units in its own certified clean room. Minimum engagement is not publicly disclosed. Works best with clients in Diagnostics & lab devices, Surgical & therapeutic devices, Wearables & remote monitoring, Drug delivery.

Who should choose Sagentia Innovation?

A typical fit: surgical robot subsystem development.

Medical development backed by a listed science group that also runs a regulatory consultancy. Minimum engagement is not publicly disclosed. Works best with clients in Surgical & robotics, Drug delivery, Diagnostics & lab devices.

Decision matrix: StarFish Medical vs Sagentia Innovation

Your situation Recommended choice
You need full-ownership delivery on a defined project scope StarFish Medical
You need a large dedicated team for an ongoing programme Check each company's engagement model
Your budget is at the lower end Compare: StarFish Medical (Not disclosed) vs Sagentia Innovation (Not disclosed)
You need specialist depth in a specific vertical StarFish Medical
You need staff augmentation or team extension Neither; consider alternatives that offer staff aug
You need consulting before committing to a build Both may offer discovery engagements

Use case fit: StarFish Medical vs Sagentia Innovation

Use case StarFish Medical fit Sagentia Innovation fit Winner
Taking a venture-backed device from proof of concept to clinical-trial units Strong Limited StarFish Medical
Designing an optical diagnostic instrument with its consumable Strong Limited StarFish Medical
Surgical robot subsystem development Limited Strong Sagentia Innovation
Drug-device combination product engineering Limited Strong Sagentia Innovation

Verdict: StarFish Medical vs Sagentia Innovation

StarFish Medical (4.6/5) is the stronger overall choice for most Medical Device Development projects. Medtech-only practice that can build clinical and early commercial units in its own certified clean room.

Sagentia Innovation (4.1/5) is worth a look if you need drug-device combination product engineering. If your situation matches that, Sagentia Innovation is a competitive option.

Related comparisons

StarFish Medical vs Sagentia Innovation FAQ

Is StarFish Medical better than Sagentia Innovation?

StarFish Medical (4.6/5) scores higher overall, but "better" depends on your use case. StarFish Medical's strongest advantage: every project is a medical device, so design reviews, risk files and documentation follow medtech practice by default. Sagentia Innovation's strongest advantage: active surgical robotics software and hardware hiring shows current work in that area.

How do StarFish Medical and Sagentia Innovation differ in pricing?

StarFish Medical uses phased fixed project, time and materials pricing. Sagentia Innovation uses time and materials, fixed project pricing. Neither firm publishes a full rate card; a discovery call is required for project-specific quotes.

Which is better for enterprise: StarFish Medical or Sagentia Innovation?

StarFish Medical is the larger team and typically the better enterprise-scale choice. For very large programmes, verify team size and compliance coverage directly with each company before shortlisting.

What are the main differences between StarFish Medical and Sagentia Innovation?

StarFish Medical's primary differentiator is: medtech-only practice that can build clinical and early commercial units in its own certified clean room. Sagentia Innovation's primary differentiator is: medical development backed by a listed science group that also runs a regulatory consultancy. They also differ in team size (201–250 vs 650+ (Science Group)), minimum engagement (Not disclosed vs Not disclosed), and primary industries served (Diagnostics & lab devices, Surgical & therapeutic devices vs Surgical & robotics, Drug delivery).

Verify all details directly with each company before making a decision.